Coreceptor requirements of primary HIV type 1 group O isolates from Cameroon

AIDS Research and Human Retroviruses

Volumn 15, Issue 8, 1999, Pages 707-712

  Dittmar, M T ^a   Zekeng, L ^b   Kaptue, L ^b   Eberle, J ^c   Krausslich H G ^a   Gurtler L ^c,d  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b Centre Hospitalier et Universitaire de Yaounde   (Cameroon)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GERMANY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MALE; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS ISOLATION;

ADULT; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, CCR5; RECEPTORS, CXCR4; RECEPTORS, HIV;

EID: 0033586966     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922299310791     Document Type: Article

References (43)

1. Maddon PJ, Littman DR, Godfrey M, Maddon DE, Chess L, and Axel R: The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: A new member of the immunoglobulin gene family. Cell 1985;42:93-104.
2. + T cells by a complex of the 110K viral protein and the T4 molecule. Science 1986;231:382-385.
3. Sattentau QJ, Clapham PR, Weiss RA, Beverley PC, Montagnier L, Alhalabi MF, Gluckmann JC, and Klatzmann D: The human and simian immunodeficiency viruses HIV-1, HIV-2 and SIV interact with similar epitopes on their cellular receptor, the CD4 molecule. AIDS 1988;2:101-105.
4. Clapham PR and Weiss RA: Immunodeficiency viruses. Spoilt for choice of co-receptors. Nature (London) 1997;388:230-231.
5. Moore JP: Coreceptors: Implications for HIV pathogenesis and therapy. Science 1997;276:51-52.
6. Weiss RA and Clapham PR: Hot fusion of HIV. Nature (London) 1996;381:647-648.
7. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane G-protein coupled receptor. Science 1996;272:872-877.
8. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, and Doms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996; 85:1149-1158.
9. Simmons G, Wilkinson D, Reeves JD, Dittmar MT, Beddows S, Weber J, Carnegie G, Desselberger U, Gray PW, Weiss RA, and Clapham PR: Dual-tropic, primary, syncytium-inducing HIV-1 strains that can use either Lestr or CCR5 as co-receptors for virus entry. J Virol 1996;70:8355-8360.
10. Zhang L, Huang Y, He T, Cao Y, and Ho DD: HIV-1 subtype and second-receptor use. Nature (London) 1996;383:768.
11. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, and Berger EA: CC CKR5: A RANTES. MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
12. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, and Sodroski J: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
13. Deng H, Liu R, Elmeier W, Choe S, Unutmaz D, Burkhart M, Di Marzio P, Marmon S, Sutton RE, and Hill CM, Davis CB, Peiper SC, Schall TJ, Littman DR. and Landau NR: Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 1996;381:661-666.
14. + cells is mediated by the chemokine receptor CC-CKR5. Nature (London) 1996;381:667-673.
15. Owen SM, Ellenberger D, Rayfield M, Wiktor S, Michel P, Grieco MH, Gao F, Hahn BH, and Lal RB: Genetically divergent strains of human immunodeficiency virus type 2 use multiple coreceptors for viral entry. J Virol 1998;72:5425-5432.
16. Connor RI, Sheridan KE, Ceradini D, Choe S, and Landau NR: Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals. J Exp Med 1997;185:621-628.
17. Xiao L, Rudolph DL, Owen SM, Spira TJ, and Lal RB: Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression. AIDS 1998;12: F137-F143.
18. McKnight A, Dittmar MT, Moniz-Periera J, Ariyoshi K, Reeves JD, Hibbitts S, Whitby D, Aarons E, Proudfoot AE, Whittle H, and Clapham PR: A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4. J Virol 1998;72:4065-4071.
19. Sol N, Ferchal F, Braun J, Pleskoff O, Treboute C, Ansart I, and Alizon M: Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2. J Virol 1997;71:8237-8244.
20. Heredia A, Vallejo A, Soriano V, Epstein JS, and Hewlett IK: Chemokine receptors and HIV-2. AIDS 1997;11:1198-1199.
21. Simon F, Mauclere P, Roques P, Loussert-Ajaka I, Muller-Trutwin MC, Saragosti S, Georges-Courbot MC, Barré-Sinoussi F, and Brun-Vezinet F: Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nature Med 1998;4:1032-1037.
22. Zekeng L, Gurtler L, Afane Ze E, Sam-Abbenyi A, Mbouni-Essomba G, Mpoudi-Ngolle E, Monny-Lobe M, Tapka JB, and Kaptue L: Prevalence of HIV-1 subtype O infection in Cameroon: Preliminary results. AIDS 1994;8:1626-1628.
23. Descamps D, Collin G, Loussert-Ajaka I, Saragosti S, Simon F, and Brun-Vezinet F: HIV-1 group O sensitivity to antiretroviral drugs. AIDS 1995;9:977-978.
24. Zhang L, Carruthers CD, He T, Huang Y, Cao Y, Wang G, Hahn B, and Ho DD: HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism. AIDS Res Hum Retroviruses 1997;13:1357-1366.
25. Vallejo A, Heredia A, Mas A, Lee SF, Epstein JS, Soriano V, and Hewlett IK: Tropism, coreceptor use, and phylogenetic analysis of both the V3 loop and the protease gene of three novel HIV-1 group O isolates. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:417-425.
26. Gurtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zekeng L, Tsague JM, and Kaptue L: A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994;68:1581-1585.
27. Gregory S, Collman R, James W, Gordon S, Gonzalez SF, and Nathanson N: HIV-1 pseudotype virus containing a Cocal virus genome and an HIV envelope: Construction, assay and use. J Virol Methods 1993;44:287-304.
28. Chesebro B and Wehrly K: Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity. J Virol 1988;62:3779-3788.
29. Clapham PR, McKnight A, and Weiss RA: Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: Induction and enhancement by soluble CD4. J Virol 1992;66:3531-3537.
30. McKnight A, Clapham PR, and Schulz TF: Detection of HIV entry into cells. In: HIV: A Practical Approach (Kam J, ed.), Vol. 1. Oxford, Oxford University Press, 1995, pp. 129-141.
31. Trkola A, Ketas T, Kewalramani VN, Endort F, Binley JM, Katinger H, Robinson J, Liftman DR, and Moore JP: Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J Virol 1998;72:1876-1885.
32. Cecilia D, Kewalramani VN, J O'Leary, Volsky B, Nyambi P, Burda S, Xu S, Littman DR, and Zolla-Pazner S: Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol 1998;72:6988-6996.
33. Konvalinka J, Litterst MA, Welfcer R, Kottler H, Rippmann F, Heuser AM, and Krausslich HG: An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. J Virol 1995;69:7180-7186.
34. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, Busciglio J, Yang X, Hoffmann W, Newman W, Mackay CR, Sodroski J, and Gabuzda D: CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature (London) 1997;385:645-649.
35. Gabuzda D, He J, Ohagen A, and Vallat AV: Chemokine receptors in HIV-1 infection of the central nervous system. Semin Immunol 1998;10:203-213.
36. Dittmar MT, Simmons G, Donaldson Y, Simmonds P, Clapham PR, Schulz TF, and Weiss RA: Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR. J Virol 1997;71: 5140-5147.
37. Dittmar MT, McKnight Á, Simmons G, Clapham PR, Weiss RA, and Simmonds P: HIV-1 tropism and co-receptor usage. Nature (London) 1997;385:495-496.
38. Yi Y, Rana S, Turner JD, Gaddis N, and Collman RG: CXCR-4 is expressed by primary macrophages and supports CCR5-independent infection by dual-tropic but not T-tropic isolates of human immunodeficiency virus type 1. J Virol 1998;72:772-777.
39. Simmons G, Reeves JD, McKnight A, Dejucq N, Hibbitts S, Power CA, Aarons E, Schols D, De Clercq E, Proudfoot AE, and Clapham PR: CXCR4 as a functionalcoreceptor for human immunodeficiency virus type 1 infection of primary macrophages. J Virol 1998;72:8453-8457.
40. Verani A, Pesenti E, Polo S, Tresoldi E, Scarlatti G, Lusso P, Siccardi AG, and Vercelli D: CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. J Immunol 1998;161:2084-2088.
41. McKnight A, Wilkinson D, Simmons G, Talbot S, Picard L, Ahuja M, Marsh M, Hoxie JA, and Clapham PR: Inhibition of human immunodeficiency virus fusion by a monoclonal antibody to a coreceptor (CXCR4) is both cell type and virus strain dependent. J Virol 1997;71:1692-1696.
42. van't Wout AB, Blaak H, Ran LJ, Brouwer M, Kuiken C, and Schuitemaker H: Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection. J Virol 1998;72:5099-5107.
43. Ashton LJ, Carr A, Cunningham PH, Roggensack M, McLean K, Law M, Robertson M, Cooper DA, and Kaldor JM: Predictors of progression in long-term nonprogressors. Australian Long-Term Nonprogressor Study Group. AIDS Res Hum Retroviruses 1998;14:117-121.